Lyfstone Calprotectin (CLP) quantitative test
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 07090028590013
- Basic UDI-DI Code
- B-07090028590013
- Reference
- LYFCLP001
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Calpro AS
Additional Description
The Lyfstone® Calprotectin for Synovial Fluid test is a method for risk strat- ification of infection in suspected periprosthetic joint infection (PJI) patients by determination of the calprotectin (CLP) level in human synovial fluid samples in combination with the dedicated Lyfstone® smartphone application. The test is intended as a diagnostic aid for screening of suspected PJI patients in a patient near setting or a laboratory. The test is for professional use only.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W01021199 | RHEUMATOID / INFLAMMATORY DISEASE MARKERS - OTHER |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).